Brown Advisory’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-47,466
Closed -$2.05M 1362
2018
Q2
$2.05M Buy
47,466
+43,666
+1,149% +$2.09M 0.01% 616
2018
Q1
$212K Sell
3,800
-517
-12% -$28.3K ﹤0.01% 1097
2017
Q4
$231K Buy
+4,317
New +$204K ﹤0.01% 1119
2017
Q3
Sell
-3,475
Closed -$210K 1215
2017
Q2
$210K Sell
3,475
-118
-3% -$6.99K ﹤0.01% 1130
2017
Q1
$249K Sell
3,593
-454
-11% -$31.5K ﹤0.01% 1035
2016
Q4
$269K Buy
4,047
+547
+16% +$35.6K ﹤0.01% 964
2016
Q3
$231K Hold
3,500
﹤0.01% 959
2016
Q2
$254K Sell
3,500
-3,200
-48% -$220K ﹤0.01% 904
2016
Q1
$433K Buy
6,700
+3,800
+131% +$252K ﹤0.01% 750
2015
Q4
$207K Buy
+2,900
New +$214K ﹤0.01% 899
2013
Q4
Sell
-4,400
Closed -$221K 962
2013
Q3
$221K Buy
+4,400
New +$215K ﹤0.01% 777

Other funds holding MD

Brown Advisory's MD Position: Q3 2018 in Review

Brown Advisory sold out of Pediatrix Medical (MD) in Q3 2018, closing a stake of 47,466 shares — an estimated $2.05M sold.

Brown Advisory first reported a position in MD in Q3 2013 and held it in 11 quarters. The position peaked at $2.05M in Q2 2018. 320 funds tracked by Wall St. Rank hold MD as of Q3 2018.

  • Brown Advisory reported no remaining Pediatrix Medical position as of Q3 2018 after selling out during the quarter.
  • Brown Advisory sold 47,466 Pediatrix Medical shares in Q3 2018, an estimated $2.05M.
  • Brown Advisory first reported a position in Pediatrix Medical in Q3 2013 and held it in 11 quarters.
  • Brown Advisory's Pediatrix Medical position peaked at $2.05M in Q2 2018.
  • 320 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2018.

Based on Brown Advisory's 13F filing for Q3 2018, filed 13 Nov 2018.